SCHEMBL648304

SCHEMBL648304

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1cc(OC)cc(OC)c1)CC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.41
TSHR P16473 3/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
FGFR3 P22607 2/20 0.36
KDR P35968 2/20 0.36
BCHE P06276 4/20 0.35
CRHR1 P34998 3/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
HDAC1 Q13547 1/20 0.34
FGFR1 P11362 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137356 0.93 MEN1 (0.45) C5AR1MEN1KMT2AALDH1A1CYP3A4
SCHEMBL5137557 0.92 C5AR1 (0.42) C5AR1TSHRMEN1KMT2ABCHE
SCHEMBL651027 0.91 C5AR1 (0.41) C5AR1TSHRMAPK1BCHECRHR1
SCHEMBL5135791 0.90 C5AR1 (0.38) C5AR1TSHRBCHECRHR1KDM4E
SCHEMBL4766337 0.90 C5AR1 (0.38) C5AR1TSHRMEN1KMT2ABCHE
SCHEMBL5137864 0.89 C5AR1 (0.44) C5AR1TSHRMAPK1BCHEKDM4E
SCHEMBL648140 0.88 C5AR1 (0.44) C5AR1MEN1KMT2AALDH1A1DRD2
SCHEMBL650474 0.88 C5AR1 (0.42) C5AR1TSHRBCHECRHR1KDM4E
SCHEMBL5135852 0.88 C5AR1 (0.40) C5AR1MEN1KMT2ABCHECRHR1
SCHEMBL648532 0.88 C5AR1 (0.41) C5AR1TSHRMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed